In a recent study, samples from patients with ME/CFS have demonstrated altered methylation and gene expression levels for the ACE and ACE2 locus, suggesting that the patients may have a higher risk of being infected with SARS-CoV-2 (36). Here, ACE2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.